IPO

Zenith Drugs Limited IPO

NSE SME

Listed On: Feb 27, 2024 at ₹ 110.0

₹ 252800 /3200 Shares
*Min Investment

Check Allotment

19 Feb, 2024

Open Date

22 Feb, 2024

Close Date

23 Feb, 2024

Allotment Date

27 Feb, 2024

Listing Date
Zenith Drugs Limited IPO Issue Details
  • Issue Price ₹75-79 per equity share
  • Face Value ₹10 Per Equity Share
  • Total Issue Size 51,48,800 shares(aggregating up to ₹40.68 crore)
  • Fresh Share 51,48,800 shares(aggregating up to ₹40.68 crore)
  • Listing at NSE SME
  • List Price 110.0
  • Listing Date 2024-02-27
  • Lead Manager Gretex Corporate Services Limited
  • Registrar Bigshare Services Pvt Ltd
Market Lot Size

Investors can bid for a minimum of 1600 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.

ApplicationLotsSharesAmount
Retail (min)11600₹1,26,400
Retail(max)11600₹1,26,400
NII (min) 23,200₹2,52,800
Zenith Drugs Limited IPO Reservation

Zenith Drugs Limited IPO offers total 5,148,800 shares. Out of which 859,200 (16.69%) allocated to QIB, 644,800 (12.52%) allocated to NII,1,504,000 (29.21%) allocated to RII, NA (NA%) allocated to employees and 1,288,000 (25.02%) allocated to Anchor investors.

Investor CategoryShares OfferedMaximum Allottees
Anchor Investor Shares Offered1,288,000 (25.02%)
Market Maker Shares Offered852,800 (16.56%)
QIB Shares Offered859,200 (16.69%)
NII (HNI) Shares Offered644,800 (12.52%)
Retail Shares Offered1,504,000 (29.21%)
Total Shares Offered5,148,800 (100%)
Zenith Drugs Limited IPO Documents
Zenith Drugs Limited IPO Details


Zenith Drugs Limited IPO is an SME IPO, priced at ₹75-79 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the NSE SME platform. The IPO comprises a total issue of 51,48,800 equity shares, aggregating up to ₹40.68 crores..

The IPO bidding window is open from Feb 19, 2024 to Feb 22, 2024. The allotment is expected to be finalized on Feb 23, 2024, and the tentative listing date is Feb 27, 2024.

The minimum lot size for Retail investors is 1600 shares, with a minimum investment of ₹1,26,400. For HNIs, the minimum application size is 2 lots , amounting to ₹ 2,52,800.

Gretex Corporate Services Limited is acting as the lead manager to the issue. The registrar of the IPO is Bigshare Services Pvt Ltd, and Gretex Share Broking Private Limited will act as the market maker for this issue.

Read More
Zenith Drugs Limited IPO Subscription Analysis And Details
Retail
138.57x
Total
179.07x
As onQIB / NIIRetailTotal
Shares Offered / Reserved859,200 / 644,8001,504,0003,008,000
Day 1 19-02-24 06:00 PM
0.00 / 0.99 x3.42 x1.92 x
Day 2 20-02-24 06:00 PM
3.53 / 2.50 x9.41 x6.25 x
Day 3 21-02-24 06:00 PM
3.54 / 7.98 x19.42 x12.43 x
Day 4 22-02-24 06:00 PM
106.72 / 369.94 x138.57 x179.07 x

Total No of Applications
1,30,900
Zenith Drugs Limited Valuations
EPS Pre IPO ₹4.29/-
EPS Post IPO ₹6.29/-
P/E Pre IPO 18.4
P/E Post IPO 12.56
ROE 35.13%
ROCE 37.29%
Debt/Equity 1.51
RoNW 29.88%
Price to Book Value 5.50
Zenith Drugs Limited Company Financials
In Lakhs
In Lakh
30-Sep-2331-Mar-2331-Mar-22
Assets11,249.049,793.836,858.47
Revenue6,948.4311,569.659,266.63
Profit After Tax539.38515.29312.86
Net Worth2,264.961,724.421,209.09
Reserves & Surplus1,064.961,684.421,169.09
Total Borrowing2,902.812,605.031,880.86
About Zenith Drugs Limited Company

Zenith Drugs Limited is a pharma company which was incorporated in the year 2000. Its products include medicines that are highly quality and are sold at relatively low prices in the market as well as generics.

The organization complies with WHO-GMP and has got ISO 9001:2015 certification issued by EuroUK recognized certification body.

Product portfolio comprises of:
ORS Powder
Liquid Orals
Ointments;
Liquid Externals; and
Capsules

The Food & Drugs Administration has certified more than 600 products from the company that are being put into production 325 in stock.The establishment of a manufacturing facility in an area known as Village Muradpura at Depalpur, Indore, Madhya Pradesh is under operation.

The company sells its products to countries in Central America and the Caribbean and Pacific regions, Malawi, Mauritius, Mozambique, Sudan, Tanzania, Bhutan, Cambodia in Southeast Asia, Tajikistan, Liberia, Sierra Leone, and Conakry.Zenith Drugs Limited is into third-party manufacturing, or white label manufacturing, for respected pharmaceutical companies like Ajanta Pharma, Bio Medical Laboratories, and Zest Pharma, among others.

As of 31 March, 2023, there were 89 staff; 61 of them were payroll employees while the rest are 28 are contractual.

Read More
Zenith Drugs Limited - Promoter(s)

Mr. Sandeep Bhardwaj

Mr. Bhupesh Soni

Mr. Ajay Singh Dassundi

Pre Issue Share Holding : 100%

Post Issue Share Holding : 69.68%

Zenith Drugs Limited IPO - Issue Objectives
1

Purchase of Machinery & Equipments for Setting up New Unit

2

Existing Manufacturing Block Upgradation

3

Working Capital Requirements

4

General Corporate Purposes.

Contact Details

Zenith Drugs Limited

K. No. 72 / 5, Village Muradpura, NA Depalpur, Indore-453001

+91 8435501867

info@zenithdrugs.com

https://zenithdrugs.com/